Search clinical trials for: Nephropathy

Total 1059 results

Arog Pharmaceuticals, Inc.

Completed

Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification

Recurrent/Refractory Glioblastoma

United States
Albert Einstein Healthcare Network

Completed

Can Rivaroxaban Lead to Anticoagulation-Related Nephropathy?

Acute Kidney Injury

United States
M.H.H. Kramer
AstraZeneca

Completed

Renoprotective Effects of Dapagliflozin in Type 2 Diabetes (RED)

Diabetes Mellitus, Type 2 | Diabetic Nephropathies

Netherlands
Rigshospitalet, Denmark
Steno Diabetes Center Copenhagen

Completed

Glycaemic Markers in Persons With Type 2 Diabetes on Haemodialysis (GLYCOHEMO)

Type2 Diabetes | Diabetic Nephropathy Type 2

Denmark
Guangdong Provincial People's Hospital

Terminated

Membranous Nephropathy-associated Serological Antibody Predict the Prognosis of Idiopathic Membranous Nephropathy

Idiopathic Membranous Nephropathy

China
Gilead Sciences

Completed

Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)

Lupus Membranous Nephropathy

United States
Cairo University

Completed

Relation Between Plasma Apelin Level and Diabetic Nephropathy in Type 2 Diabetes Patients.

Diabetic Nephropathies

Egypt
National Institute of Diabetes and Digestive and...
Case Western Reserve University

Completed

The Family Investigation of Nephropathy and Diabetes Study (FIND)

Diabetes | Diabetic Nephropathy

United States
Nahla H Tohami

Unknown

Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients

Diabetic Nephropathies

Egypt
Augusta University
National Heart, Lung, and Blood Institute (NHLBI); Gilead Sciences

Completed

The Role of Endothelin-1 in Sickle Cell Disease

Sickle Cell Anemia

United States
University of Oxford
Novartis; Pfizer; National Health Service, United Kingdom

Completed

Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy (3C)

Kidney Transplantation

United Kingdom
University of North Carolina, Chapel Hill
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effect of Atorvastatin on Endothelial Dysfunction and Albuminuria in Sickle Cell Disease (ENDO)

Sickle Cell Disease | Sickle Cell Nephropathy

United States
Nanfang Hospital of Southern Medical University

Completed

Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy

Diabetic Nephropathies
Visterra, Inc.

Completed

First in Human Study to Assess Safety of VIS649 in Healthy Subjects

Immunoglobulin A Nephropathy | IgA Nephropathy | IgAN - IgA Nephropathy

United States
Odense University Hospital

Unknown

Low Energy Shockwave Therapy (LE-SWT): A Novel Treatment for Chronic Kidney Disease

Diabetic Nephropathies

Denmark
King's College London
Roche Pharma AG; Medical Research Council

Completed

Study of Rituximab to Treat Chronic Renal Transplant Rejection (RituxiCAN-C4)

Kidney Transplantation | Graft Rejection | Immunosuppression

United Kingdom
Hospital Universitario Ramon y Cajal

Completed

Sodium Chloride and Contrast Nephropathy

Heart Failure | Diabetes | Kidney Failure, Chronic | Kidney Failure, Acute

Spain
CAMC Health System

Unknown

Single-Center Prospective Study to Investigate the Difference in the Incidence of Contrast-Induced Nephropathy in High-Risk Patients With the Use of the Dye-Vert Plus System (Dye-Vert Plus)

AKI (Acute Kidney Injury) Due to Trauma

United States
Shenzhen Second People's Hospital

Unknown

Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency

Renal Insufficiency, Chronic | Glomerulonephritis, IGA

China
Andre Barreto Pereira
Novartis

Completed

Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant

Immunosuppression | Renal Transplant Rejection

Brazil
R. Laura Vicente Vicente
Salamanca University Hospital; Instituto de Investigación Biomédica de Salamanca and other collaborators

Completed

Early Diagnosis as Strategy in Reducing the Incidence of Contrast-induced Nephropathy

Kidney Injury | Contrast-induced Nephropathy

Spain
Agnieszka Pozdzik

Completed

Influence of Iodinated Contrast Volume Injected During Coronarography on Contrast Nephropathy.

Nephropathy

Belgium
Changi General Hospital
University College Hospital Galway

Completed

Use of Remote Ischaemic Preconditioning in the Prevention of Contrast Induced Nephropathy

Contrast Induced Nephropathy | Remote Ischaemic Preconditioning

Singapore
University Hospital, Limoges

Unknown

Study of the IgA Repertoire During IgA Deposition Nephropathy. (ERINA)

Glomerulonephritis, IGA

France
Hospital Universitario 12 de Octubre
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz; Fundación... and other collaborators

Completed

Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy (STARMEN)

MEMBRANOUS NEPHROPATHY

Spain
Beni-Suef University

Unknown

Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination

Diabetic Nephropathy Type 2 | Microalbuminuria Due to Type 2 Diabetes Mellitus

Egypt
Boehringer Ingelheim

Completed

This Study Tests a New Medicine Called BI 685509 in Patients That Have Kidney Problems Because of Diabetes. The Study Tests How BI 685509 is Taken up in the Body and How Well it is Tolerated (Multiple Rising Doses)

Diabetic Nephropathies

United States, Canada, Belgium, Czechia, Germany
Ospedale Misericordia e Dolce

Unknown

Tailored Hydration Based on Bioimpedance Analysis for Prevention of Contrast Induced Acute Kidney Injury (Hydra2)

Acute Kidney Injury

Italy
National Institute of Diabetes and Digestive and...

Completed

Kidney Disease Biomarkers

Focal Segmental Glomerulosclerosis | Glomerular Disease | Kidney Disease | Idiopathic Nephrotic Syndrome | Collapsing Glomerulopathy

United States
Janssen Research & Development, LLC
The George Institute for Global Health, Australia

Completed

Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy (CREDENCE)

Diabetes Mellitus, Type 2 | Diabetic Nephropathy

United States, Canada, France, Germany, Poland, Ukraine, United Kingdom, China, Taiwan, Spain, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Serbia, South Africa, Japan, Australia, Korea, Republic of, Chile, New Zealand and more
S-There Technologies SL
Biocruces Bizkaia Health Research Institute; Hospital de Cruces

Unknown

Clinical Validation Through Analytical Study With Urine Samples to Compare the Effectiveness and Security of an Intelligent Device (STSD-2019-001)

Heart Failure | Renal Insufficiency, Chronic | Urinary Tract Infections | Diabete Mellitus | Hematuria | Diabetes; Nephropathy (Manifestation)

Spain
Sun Yat-sen University

Completed

Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)

IgA Nephropathy

China
Assiut University

Unknown

Nephropathy in Patients With Sickle Cell Disease

Sickle Cell Nephropathy
Mackay Memorial Hospital

Unknown

The Evaluation of Effect of Sanyinjiao (SP6) Acupressure on Early Diabetic Nephropathy

Diabetic Nephropathy

Taiwan
Mallinckrodt

Completed

Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients (CHART)

Proteinuria | Idiopathic Membranous Nephropathy

United States, Canada, Chile, Mexico, Turkey
Mallinckrodt

Completed

Acthar for Treatment of Proteinuria in Diabetic Nephropathy Patients

Diabetic Nephropathy

United States
Maastricht University Medical Center

Completed

Contrast-Induced Nephropathy After Revision of the Prophylaxis Threshold (CINART)

Contrast-induced Nephropathy

Netherlands
Istanbul University

Completed

Rituximab in Refractory Primary Membranous Nephropathy

Glomerulonephritis, Membranous

Turkey
The Methodist Hospital Research Institute

Completed

Ciprofloxacin for Prevention of BK Infection

BK Virus Infection

United States
Institute of Liver and Biliary Sciences, India

Completed

N-Acetyl Cysteine in the Prevention of Contrast Induced Nephropathy in Cirrhosis of Liver-NEPHRO Trial

Liver Cirrhoses

India
I.M. Sechenov First Moscow State Medical University

Completed

CI-AKI in Patients With Stable CAD and Comorbidities. Are we Doing Better?

Acute Kidney Injury | Stable Angina | Contrast-induced Nephropathy
Mt. Sinai Medical Center, Miami
Florida Heart Research Institute

Completed

Contrast Nephropathy and Nitrates (CoNaN)

Contrast Induced Nephropathy

United States
Zhongshan Hospital Xiamen University

Unknown

Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes

Diabetic Nephropathy | Type 2 Diabetes

China
The Third Xiangya Hospital of Central South University

Completed

Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan

Type 2 Diabetic Nephropathy

China
Chang Gung Memorial Hospital

Unknown

Use of GDF15 as a Biomarker for Early Diagnosis of DM and Monitoring of Progress of Complications in Asians

Diabetes Mellitus, Type 2 | Diabetic Nephropathies | Diabetic Polyneuropathy

Taiwan
The Western Pennsylvania Hospital
West Penn Allegheny Health System

Withdrawn

Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy (HYDRATE)

Contrast Induced Nephropathy

United States
Eli Lilly and Company

Completed

Study of LY3016859 in Participants With Diabetic Nephropathy

Diabetic Nephropathy

United States, Bulgaria
Eli Lilly and Company

Terminated

A Study in Participants With Diabetic Kidney Disease

Diabetic Nephropathy | Diabetic Kidney Disease | Diabetic Glomerulosclerosis

Israel, Hungary, United States, Australia, France, Czechia, Puerto Rico
Assiut University

Unknown

TCF7L2 Gene Polymorphism and AGEs in Diabetic Nephropathy

Diabetic Nephropathies
Fayoum University

Completed

Hypomagnesemia and Diabetic Nephropathy

Diabetic Nephropathies

Egypt

Search clinical trials for: Nephropathy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations